Mon, 27th Oct 2014 16:25
LONDON (Alliance News) - GlaxoSmithKline PLC Monday said Chairman Moncef Slaoui exercised options over 26,800 shares at an option price of GBP11.23 per share under the company share plan. He then sold the shares at a price of GBP14.16 pence per share.
The stock was trading at 1,400.50 pence down 1.1% Monday.
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2014 Alliance News Limited. All Rights Reserved.
Sees $80 bln in 2030 revenue by 2030 *
(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatm...
(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating seve...
GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares ...
Haleon falls after GSK offloads remaining stake *
Glaxosmithkline (GSK)